Intrauterine Devices Market Forecasts to 2030 – Global Analysis By Type (Hormonal IUDs, Non-Hormonal IUDs and Other Types), Material, Age Group, End User and By Geography

Intrauterine Devices Market Forecasts to 2030 – Global Analysis By Type (Hormonal IUDs, Non-Hormonal IUDs and Other Types), Material, Age Group, End User and By Geography

According to Stratistics MRC, the Global Intrauterine Devices Market is accounted for $6.6 billion in 2024 and is expected to reach $9.15 billion by 2030 growing at a CAGR of 5.6% during the forecast period. Intrauterine devices (IUDs) are small, T-shaped medical devices inserted into the uterus to provide long-term, reversible contraception. They work by preventing sperm from fertilizing an egg or altering the uterine lining to prevent implantation. IUDs are highly effective, with hormonal and non-hormonal options available. Hormonal IUDs release progestin, while copper IUDs use copper to create a toxic environment for sperm. IUDs are a popular choice due to their convenience, cost-effectiveness, and long duration of action, lasting up to 5-10 years.

According to data by Family Planning NSW, hormonal IUDs are found to have an edge over copper intrauterine devices in terms of efficiency where they provide 99.8% efficiency over copper IUDs, which provide 99.2% efficiency.

Market Dynamics:

Driver:

Rising awareness of family planning

The demand for effective and long-lasting contraception like IUDs is increasing due to increased awareness among women about reproductive health options. This is fuelled by government campaigns, healthcare programs, and community outreach, as well as increased accessibility of information through media and social platforms. Additionally, changing societal attitudes towards family planning and women's reproductive rights have encouraged open conversations about contraception. As a result, more women are choosing IUDs as a reliable and convenient method of birth control, contributing to the IUD market expansion.

Restraint:

Lack of awareness and misconceptions

Lack of awareness and misconceptions, especially in developing regions, are not fully informed about the safety and efficacy of IUDs, leading to hesitations in choosing this method of contraception. Misunderstandings regarding potential side effects, such as pain, discomfort, or infertility, further discourage usage. Cultural and societal taboos around birth control also prevent women from seeking IUDs as an option. As a result, despite their effectiveness and long-term benefits, IUDs remain underutilized in certain markets, especially where educational resources are limited or there is a lack of healthcare provider support.

Opportunity:

Telemedicine and remote consultations

The use of virtual consultations and IUD insertions has revolutionized the reproductive health industry by breaking down geographical barriers, providing convenient access to expert consultations, reducing anxiety, improving education, and facilitating efficient follow-up appointments. In addition, it reduces healthcare expenses, offers prompt access, and permits individualised counselling regarding the advantages and disadvantages of IUDs. Virtual consultations provide a comfortable and private setting for discussing sensitive topics, while IUD insertions ensure optimal efficacy and safety. This has led to increased awareness, uptake, and satisfaction with IUDs, ultimately driving market growth.

Threat:

Adverse publicity and safety concerns

Adverse publicity and safety concerns, such as perforation, infection, or expulsion of the device, can create fear among potential users. Safety concerns about side effects, including irregular bleeding, hormonal imbalances, or pain during insertion, may deter women from choosing IUDs. Additionally, misinformation and anecdotal reports can amplify fear, especially in regions with limited awareness and education. Adverse publicity from previous lawsuits or recalls regarding certain IUD brands may erode trust in the product. These factors lead to reduced demand and hesitation among healthcare providers to recommend IUDs, limiting market growth.

Covid-19 Impact

The COVID-19 pandemic negatively impacted the intrauterine device (IUD) market, primarily due to reduced access to healthcare services as lockdowns and restrictions limited elective procedures. Many patients faced delays or cancellations in appointments, disrupting IUD insertions and replacements. Supply chain disruptions also hindered product availability. However, as restrictions eased, demand rebounded due to the resumption of reproductive health services and a renewed focus on long-term contraception options.

The hormonal IUDs segment is expected to be the largest during the forecast period

During the forecast period, the hormonal IUDs segment is anticipated to register as the largest market share, due to their enhanced benefits over non-hormonal options. Hormonal IUDs, such as Mirena, provide long-term contraception while also offering additional health benefits like reduced menstrual bleeding and management of conditions like endometriosis. Their ability to release hormones gradually, such as levonorgestrel, makes them popular among women seeking reliable, low-maintenance contraception. The segment is expanding with growing awareness and rising preference for hormonal IUDs in regions with improving healthcare access.

The hospitals segment is expected to have the highest CAGR during the forecast period

During the projection period, the hospitals segment is expected to grow at the highest CAGR, by providing a trusted healthcare setting for insertion and consultation. Hospitals offer a comprehensive range of reproductive health services, making them a primary point of access for women seeking long-term contraception. Additionally, hospitals provide the necessary infrastructure and skilled professionals for proper IUD insertion, reducing the risk of complications. Increased awareness, government programs, and expanding healthcare services within hospitals are driving the adoption of IUDs. Hospitals also serve as platforms for educating women on the benefits of IUDs, contributing to market growth.

Region with largest share:

During the estimation period, the Asia Pacific region is expected to capture the largest market share due to improved healthcare infrastructure. Countries like India and China are witnessing higher adoption rates as family planning programs and government initiatives promote IUD use. Despite cultural barriers and misconceptions, the availability of both hormonal and copper IUDs is helping drive market expansion. Additionally, rising disposable incomes, access to healthcare, and increasing awareness about reproductive health are propelling demand across this region.

Region with highest CAGR:

The North America region is projected to achieve the highest CAGR during the forecast period, owing to supportive healthcare policies. The U.S. and Canada have seen a rise in demand for IUDs as an effective, low-maintenance birth control method, driven by a focus on women’s health. Government initiatives and health insurance coverage for reproductive health services have also boosted market growth. Additionally, technological advancements in IUD designs, including hormone-releasing options, contribute to their popularity. However, misconceptions and side effect concerns remain challenges to wider adoption.

Key players in the market

Some of the key players profiled in the Intrauterine Devices Market include Bayer AG, Teva Pharmaceutical Industries Ltd., Allergan plc, CooperSurgical Inc., DKT International, HLL Lifecare Limited, SMB Corporation of India, Pregna International Limited, Meril Life Sciences Pvt. Ltd., Medisafe Distribution Inc., China RH Contraceptives Co., Ltd., Mona Lisa N.V., Prosan International B.V., Ocon Medical Ltd., Egemen International, Besins HealthCare, Shenyang Liren Gynecology Health Technology Co., Ltd., Cupid Limited, Bersil Contraceptives Pvt. Ltd. and Sanghai Dahua Medical Apparatus Co., Ltd.

Key Developments:

In August 2024, Teva and Alvotech received FDA approval for an additional presentation of SELARSDI® (ustekinumab), a biosimilar to Stelara®. This partnership leverages Alvotech’s expertise in biosimilars and Teva’s commercialization capabilities to expand the treatment options for autoimmune disorders in the U.S. market.

In August 2024, CooperSurgical acquired obp Surgical, a company specializing in single-use surgical devices with integrated lighting. This acquisition, valued at approximately $100 million, enhances CooperSurgical's range of devices, particularly through the ONETRAC™ surgical retractors and suction devices, designed to improve clinical efficiency in various surgical procedures.

In July 2024, Teva announced collaboration with Launch Therapeutics to accelerate the clinical development of an innovative asthma inhaler combining an inhaled corticosteroid with a short-acting beta-agonist (ICS-SABA), aiming to improve outcomes for asthma patients. This project is part of Teva's commitment to advancing respiratory therapies.

Types Covered:
• Hormonal IUDs
• Non-Hormonal IUDs
• Other Types

Materials Covered:
• Hormonal (Levonorgestrel)
• Copper
• Other Materials

Age Groups Covered:
• Teenagers
• Adult Women
• Other Age Groups

End Users Covered:
• Hospitals
• Gynaecology Clinics
• Community Healthcare Centers
• Home Care Settings
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements